PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory t cells and rituximab in type 1 diabetes children via regulatory t cells suppressive activity…

Overview of attention for article published in International Immunopharmacology, March 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#6 of 4,572)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 44 news stories from 44 outlets.

PolTREG S.A. recemtly announced it has published data in International Immunopharmacology, which suggest that PD-1+ T-cells are…

New biomarker may facilitate monitoring T1D patients’ health Increase in PD-1+ T-cells correlated with therapeutic response and…

Gdansk, Poland – 4 April 2024 – PolTREG S.A. (Warsaw Stock Exchange: PTG), a clinical-stage biotechnology company developing…

New biomarker may facilitate monitoring T1D patients’ health Increase in PD-1+ T-cells correlated with therapeutic response and…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 40 additional news stories.